Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Segesterone Acetate,Ethinyl Estradiol
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Study Phase : Approved
Sponsor : TherapeuticsMD
Deal Size : Undisclosed
Deal Type : Agreement
TherapeuticsMD and Nurx Expand Access to ANNOVERA®
Details : The agreement is aimed at expanding access to ANNOVERA® (segesterone acetate and ethinyl estradiol vaginal system), a first of its kind annual birth control ring. ANNOVERA is the first FDA-approved long-lasting birth control method that does not require...
Brand Name : Annovera
Molecule Type : Small molecule
Upfront Cash : Undisclosed
July 15, 2020
Lead Product(s) : Segesterone Acetate,Ethinyl Estradiol
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Highest Development Status : Approved
Sponsor : TherapeuticsMD
Deal Size : Undisclosed
Deal Type : Agreement
LOOKING FOR A SUPPLIER?